Gambia: Our Products Not Behind Gambia Deaths - Maiden Pharmaceuticals Md

13 October 2022
The Point (Banjul)

Naresh Goyal, managing director of Maiden Pharmaceuticals - which is in the dock for allegedly causing deaths of 66 children in The Gambia - on Tuesday claimed their products had nothing to do with the deaths.

Goyal said The Gambia government is carrying out quality control analysis of his products and it's premature to taint his company with accusations that children have died due to cough syrups manufactured by Maiden Pharmaceuticals.

"Medicines Control Agency (national medicines regulator of The Gambia) only recalled the products. They never said that they resulted in deaths," he said. "The deaths have been due to paracetamol syrup and not due to our cough syrups," he said. Goyal said his company follows the WHO -approved manufacturing practices and is certified by International Organisation for Standardisation. A person familiar with Maiden Pharma said, "The company fulfils all requirements to export products. All quantity. Source Economic Times

Read the original article on The Point.

Tagged:
Copyright © 2022 The Point. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.